The Non-Hodgkins Lymphoma Market is estimated to be valued at US$ 6.60 billion in 2022 and is expected to exhibit a CAGR of 8.4% over the forecast period 2019-2026, as highlighted in a new report published by Coherent Market Insights.Market Overview:Non-Hodgkins Lymphoma is a type of cancer that affects the lymphatic system, a part of the immune system. The market offers a range of treatment...
0 Commentarios
0 Acciones
1242 Views
0 Vista previa